Cycloastragenol targets Fpr2 to inhibit the TLR4/NF-κB signaling pathway and alleviate neuroinflammation in Parkinson's disease
Shengnan Xiao, Lianmei Liu, Xuemei Qin, Lei Xu, Zhi Chai, Zhenyu Li
Topics & Concepts
NeuroinflammationNeuroprotectionPharmacologySignal transductionParkinson's diseaseTLR4MPTPNF-κBInflammationMechanism of actionBiologyNeuroscienceMedicineCell biologyDiseaseIn vitroImmunologyBiochemistryInternal medicineParkinson's Disease Mechanisms and TreatmentsTraditional Chinese Medicine AnalysisNeuroinflammation and Neurodegeneration Mechanisms